S
Zodix
Study
Academic Library
Search
Shelves
Open access
Sign in
Search or jump to…
⌘K
Friederike Holze · Study
Home
/
Author
Friederike Holze
14 works
· latest 2023
· 1 institutions
cluster: provisional
ORCID 0000-0003-3143-1519
Follow
Suggest an ORCID correction
h-index
14
i10
14
Citations
2,137
Works here
14
19
20
21
22
23
Most cited in this library
Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study
2022 · 316 citations
Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
2019 · 246 citations
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
2020 · 242 citations
Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
2022 · 225 citations
Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects
2021 · 184 citations
Works
14 shown
Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants
Neuropsychopharmacology
·
2023
·
14 authors
·
Open access
129
citations
Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants
Translational Psychiatry
·
2023
·
15 authors
·
Open access
89
citations
Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial
The Lancet Diabetes & Endocrinology
·
2023
·
11 authors
64
citations
Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants
Clinical Pharmacology & Therapeutics
·
2022
·
5 authors
·
Open access
120
citations
Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants
The International Journal of Neuropsychopharmacology
·
2022
·
8 authors
·
Open access
104
citations
Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study
Biological Psychiatry
·
2022
·
5 authors
·
Open access
316
citations
Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
Neuropsychopharmacology
·
2022
·
12 authors
·
Open access
225
citations
Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects
Clinical Pharmacology & Therapeutics
·
2021
·
11 authors
·
Open access
184
citations
Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study
European Neuropsychopharmacology
·
2020
·
9 authors
·
Open access
123
citations
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
Neuropsychopharmacology
·
2020
·
11 authors
·
Open access
242
citations
Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers
ACS Pharmacology & Translational Science
·
2020
·
11 authors
·
Open access
130
citations
A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers
Journal of Psychopharmacology
·
2020
·
9 authors
·
Open access
92
citations
Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
Neuropsychopharmacology
·
2019
·
9 authors
·
Open access
246
citations
Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects
British Journal of Clinical Pharmacology
·
2019
·
6 authors
·
Open access
73
citations